>>Theravance to Host Investor Conference Call Following Presentation at the Third International Symposium on Resistant Gram-Positive Infections
Friday October 6, 6:16 pm ET
SOUTH SAN FRANCISCO, CA--(MARKET WIRE)--Oct 6, 2006 -- Theravance, Inc. (NASDAQ:THRX - News) today announced that it will host an investor conference call at 8:00 a.m. Eastern Daylight Time on October 11, 2006 to discuss the results from ATLAS 1 and ATLAS 2, the telavancin Phase 3 program for the treatment of complicated skin and skin structure infections. The conference call will follow a presentation given the previous day at the Third International Symposium on Resistant Gram-Positive Infections.
Conference Call and Webcast Information
To participate in the live call, please dial 877-704-5384 from the U.S. and Canada, or 913-312-1297 for international callers. The live webcast and accompanying slides can be accessed from Theravance's web site at www.theravance.com. Please go to the web site 15 minutes prior to its start to register, download, and install any necessary audio software.
A replay of the conference call and webcast will be available on the company's web site for 30 days through November 10, 2006. An audio replay will also be available through 11:59 p.m. Eastern Daylight Time on November 10, 2006 by dialing 888-203-1112 from the U.S., or 719-457-0820 for international callers, and entering confirmation code 5592554.<<
snip
Cheers, Tuck |
